KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis

Cutting Edge: Selective Expression of Inhibitory or Activating Killer Cell Ig-Like Receptors in Circulating CD4+ T Lymphocytes

(2014) N. Remtoula et al.   JOURNAL OF IMMUNOLOGY

Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3

(2014) A. K. Moesta et al.   JOURNAL OF IMMUNOLOGY

NK cell MHC class I specific receptors (KIR): from biology to clinical intervention

(2012) Ariane Thielens et al.   CURRENT OPINION IN IMMUNOLOGY

Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections

(2012) Saray Aranda-Romo et al.   IMMUNOGENETICS

Killer cell immunoglobulin-like receptor (KIR) gene content variation in the HGDP-CEPH populations

(2012) Jill A. Hollenbach et al.   IMMUNOGENETICS

HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1

(2012) Jeffrey M. Venstrom et al.   NEW ENGLAND JOURNAL OF MEDICINE

KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population

(2011) N. Tajik et al.   International Journal of Immunogenetics

Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells

(2010) Céline Cognet et al.   CLINICAL IMMUNOLOGY

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors

(2010) Suliman Al Omar et al.   HUMAN IMMUNOLOGY

HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer

(2010) Maureen P. Martin et al.   IMMUNOGENETICS

Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3–CD16+ NK cells

(2009) Gordana Konjević et al.   BIOMARKERS

Education of human natural killer cells by activating killer cell immunoglobulin-like receptors

(2009) C. Fauriat et al.   BLOOD

Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines

(2009) Javier G. Casado et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus

(2009) Susanne Knapp et al.   HEPATOLOGY

The extensive polymorphism of KIR genes

(2009) Derek Middleton et al.   IMMUNOLOGY

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C

(2009) Thorsten Graef et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells

(2009) Paolo Carrega et al.   PLoS One

The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations

(2008) B. A. Foley et al.   BLOOD

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

(2008) D. Pende et al.   BLOOD

Changes in the presentation of nodular and superficial spreading melanomas over 35 years

(2008) Melanie A. Warycha et al.   CANCER

Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells

(2008) Sonja Verheyden et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY